Lesovir-C® is a fixed-dose combination of ledipasvir and sofosbuvir used to treat chronic hepatitis C genotype 1or genotype 4 infection in adults. It is not known if the combination is safe and effective in children under 18 years of age.
Recommended dosage: One tablet (90 mg of Ledipasvir and 400 mg of Sofosbuvir) taken orally once daily with or without food
Recommended treatment duration:
Treatment-naive with or without cirrhosis: 12 weeks
Treatment-experienced without cirrhosis: 12 weeks
Treatment-experienced with cirrhosis: 24 weeks
A dose recommendation cannot be made for patients with severe renal impairment or end stage renal disease.